Key result
The ValveClamp system for transcatheter edge-to-edge mitral valve repair was feasible and safe in a porcine model, achieving an acute procedure success rate of 92.3%.
Why the study?
The study evaluated the feasibility and safety of the ValveClamp system, a novel transapically delivered edge-to-edge mitral valve repair system designed for ease of operation, in a porcine model.
Does the ValveClamp system provide feasible and safe transcatheter edge-to-edge mitral valve repair in a porcine model?
Does the ValveClamp system provide feasible and safe transcatheter edge-to-edge mitral valve repair in a porcine model?
The ValveClamp system is a feasible and safe novel device for transcatheter edge-to-edge mitral valve repair in a preclinical porcine model.
Supports further ValveClamp development; leaves open translation to human transcatheter mitral repair.
OBJECTIVES: The present study was performed to evaluate the feasibility and safety of the ValveClamp system for transcatheter edge-to-edge mitral valve repair in a porcine model. BACKGROUND: The ValveClamp system is a novel, transapically delivered edge-to-edge mitral valve repair system designed for ease of operation. METHODS: Thirteen young adult swine were enrolled in the study. The procedure was performed via the transapical approach under epicardial echocardiography guidance. RESULTS: The acute procedure success rate was 92.3% (12/13). The catheter manipulation time was just 18.5 ± 8.2 min. Four pigs were explanted on the 14th day after the procedure. One pig died at the 20th day because of pneumonia. The other eight pigs lived to the study endpoint (140 days). No pig had severe mitral valve dysfunction. The gross observation showed that the clamp device was securely attached and created a double-orifice mitral valve in all pigs except the failed one. In the eight pigs living to the endpoint, the clamp device was noted to be completely endothelialized. None of the 13 pigs developed infective endocarditis, thrombosis, thromboembolism, or valve impairment. In two pigs for which mitral regurgitation (MR) was created, the degree of MR was reduced from severe to trace after the device implantation. CONCLUSIONS: It was feasible and safe to use ValveClamp to perform a catheter-mediated edge-to-edge mitral valve repair in a porcine model. This system is potentially applicable as a novel user-friendly system for the treatment of MR.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2018) studied Mitral regurgitation (porcine model) (n=13). ValveClamp system was evaluated on Acute procedure success rate. The ValveClamp system for transcatheter edge-to-edge mitral valve repair was feasible and safe in a porcine model, achieving an acute procedure success rate of 92.3%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: